Join date: Apr 15, 2022

Prisys established the unique CRO Pharmacology platform by successful integration of its proprietary NHP disease modeling expertise and rich pharmacology experience with well-organized local monkey resources and top-equipped clinical hospitals, enabling global pharmaceuticals to access monkey studies in the way of both environmental and cost effectiveness. Prisys welcomes flexible, broad and dedicated collaborations worldwide for quick establishment and/or co-development of disease models, technologies and exploratory studies targeting at the specific interests in translational NHP pharmacology to the human applications.

More actions